Alerts will be sent to your verified email
Verify EmailEVEREST ORG.
Everest Organics
|
NGL Fine-Chem
|
Fermenta Biotech
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
Manufacturing Capacity - Esomeprazole
|
144.0 MTPA | n/a | n/a |
Capacity Utilization - Esomeprazole
|
66.35 % | n/a | n/a |
Capacity Utilization - Benzimidazole
|
88.96 % | n/a | n/a |
Capacity Utilization - Omeprazole
|
82.67 % | n/a | n/a |
Realization - Pantaprazole Sodium
|
5992651.16 Rs/Tonne | n/a | n/a |
Realization - Ammonium Sulphate
|
22104.75 Rs/Tonne | n/a | n/a |
Realization - Esomeprazole Magnesium
|
4781535.7 Rs/Tonne | n/a | n/a |
Realization - Chloro Compound
|
2039819.1 Rs/Tonne | n/a | n/a |
Manufacturing Capacity - Pantaprazole
|
60.0 MTPA | n/a | n/a |
Realization - Omeprazole Powder
|
3011676.72 Rs/Tonne | n/a | n/a |
Manufacturing Capacity - Benzimidazole
|
250.0 MTPA | n/a | n/a |
Capacity Utilization - Chloro Compound
|
18.85 % | n/a | n/a |
Realization - Benzimidazole
|
1270727.38 Rs/Tonne | n/a | n/a |
Realization - Op. Sulphide
|
2949666.67 Rs/Tonne | n/a | n/a |
Capacity Utilization - Pantaprazole
|
11.08 % | n/a | n/a |
Manufacturing Capacity - Chloro Compound
|
480.0 MTPA | n/a | n/a |
Realization - Tetralone
|
700000.0 Rs/Tonne | n/a | n/a |
Manufacturing Capacity - Omeprazole
|
215.0 MTPA | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.16 % | 0.94 % | 3.87 % |
Financials
|
|||
5 yr Average ROE
|
18.45 % | 20.08 % | 13.3 % |
5yr average Equity Multiplier
|
3.75 | 1.43 | 2.01 |
5yr Average Asset Turnover Ratio
|
1.24 | 1.08 | 0.57 |
5yr Avg Net Profit Margin
|
3.87 % | 12.69 % | 10.11 % |
Price to Book
|
2.31 | 5.89 | 1.7 |
P/E
|
551.71 | 37.09 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-58.09 Days | 67.77 Days | 87.0 Days |
Inventory Days
|
53.31 Days | 51.05 Days | 127.28 Days |
Days Receivable
|
126.69 Days | 85.22 Days | 67.14 Days |
Days Payable
|
204.46 Days | 73.98 Days | 138.62 Days |
5yr Average Interest Coverage Ratio
|
3.77 | 21.07 | 3.0 |
5yr Avg ROCE
|
25.78 % | 27.12 % | 15.8 % |
5yr Avg Operating Profit Margin
|
9.2 % | 22.47 % | 23.21 % |
5 yr average Debt to Equity
|
0.75 | 0.2 | 0.7 |
5yr CAGR Net Profit
|
n/a | 0.28 % | n/a |
5yr Average Return on Assets
|
5.35 % | 14.23 % | 6.54 % |
Shareholdings
|
|||
Promoter Holding
|
74.15 % | 72.74 % | 62.06 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -1.07 % | 2.62 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.24 % |
Everest Organics
|
NGL Fine-Chem
|
Fermenta Biotech
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Raw Material Break-Up
|
Raw Material Break-Up
|
-
|
-
|